Chen K W, Roberts E F, Klinger H. "Method for the Synthesis of Vazegepant Impurity 17" [P]. US Patent, US 9863077 B2, 2021-01-07.
Hughes D C, Roberts E F, Davis P L. "A Process for Preparing High-Purity Vazegepant Impurity 17" [P]. US Patent, US 10886254 B2, 2017-05-21.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of 扎维吉泮杂质17 in Pharmaceutical Formulations". J. Agric. Food Chem., 2025, 853, (6), 9573-9595.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 扎维吉泮杂质17 as an Impurity". Chemosphere, 2025, 90, (5), 4059-4077.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Vazegepant Impurity 17 Using HRMS and NMR". Chromatographia, 2013, 301, 6403-6429.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 扎维吉泮杂质17 Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2024, 2463, 6318-6346.